| 1 |
How might using gold nanoparticles in electrochemical sensors enhance early-stage disease detection?
|
2. By increasing surface interactions for more accurate biomarker capture |
|
Gold nanoparticles have a large surface area and special chemical properties. This helps them catch tiny disease markers (biomarkers) more easily and accurately, which is important for early-stage detection. |
“For instance, gold nanoparticles can enhance the electrochemical signal by providing a large surface area for the immobilization of biomolecules, leading to higher sensitivity in detecting low-abundance biomarkers” Page3 document “Roles of nanotechnology in electrochemical sensors for medical diagnostic purposes: A review” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following best explains how label-free electrochemical sensors support point-of-care medical diagnostics?
|
3. They provide direct measurement of target molecules with minimal preparation |
|
Label-free electrochemical sensors are useful in point-of-care diagnostics because they can detect target molecules directly without needing extra labeling or sample processing. This makes testing faster, easier, and more suitable for clinics or remote settings. |
“ Li et al. demonstrated a sensitive, label-free biosensor using single-crystalline graphene (SCG)… The deployment of digital biosensors for cancer diagnosis offers early detection, real-time monitoring, and personalized care…” Page6 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is electrochemical transduction considered advantageous over optical transduction in medical diagnostic sensors?
|
2. It is more compatible with smartphone integration for remote analysis |
|
Electrochemical biosensors have been successfully transformed into digital sensors by integrating with smartphones, AI, and ML algorithms. |
“Daizong Ji et al. developed a smartphone-based voltammetry system… to perform trace detection” and “digital optical biosensors utilize smartphone cameras to detect target molecules” This makes electrochemical transduction more suitable for remote and mobile applications compared to optical transduction. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which action would most effectively increase specificity in a sensor designed to detect a single disease biomarker?
|
3. Functionalizing the electrode with disease-specific aptamers |
|
This approach enhances specificity by allowing the sensor to only bind to a particular disease biomarker, minimizing false positives. |
“Biosensors based on nanomaterials have been tailored to target specific cancer biomarkers with exceptional sensitivity and selectivity. These platforms provide molecular specificity…” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
In a scenario where a sensor must detect ultra-low concentrations of a cancer biomarker, which modification is most critical?
|
3. Incorporating nanostructures to increase surface-to-volume ratio |
|
Incorporating nanostructures enhances the sensitivity of sensors by increasing their surface-to-volume ratio, which allows more interactions with tiny amounts of cancer biomarkers. This makes it easier to detect even ultra-low concentrations, which is critical for early diagnosis. |
“The application of nanomaterials in sensor design has significantly boosted biosensor performance, particularly in achieving ultra-sensitive detection capabilities… Through their increased surface area, enhanced electron transfer properties, and tunable optical behavior, nanomaterials improve the performance of digital sensors…” Page9 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why might two electrochemical sensors using the same nanomaterial produce inconsistent results?
|
3. Variations in nanomaterial synthesis affect structural uniformity |
|
Even if two sensors use the same type of nanomaterial, they might work differently because the way the nanomaterial was made can change its structure. If the structure is not the same, the results may not be the same either. |
“Synthesis methods can result in different structural outcomes, impacting consistency and uniformity.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which characteristic makes nanotechnology-based electrochemical sensors especially suitable for wearable medical devices?
|
3. They allow miniaturization without losing sensitivity |
|
Nanotechnology-based electrochemical sensors are great for wearable medical devices because they can be made very small (miniaturized) without reducing how well they detect things (sensitivity). This means they can fit into small, flexible devices that stick to or go inside the body and still give accurate results. |
6.2.2 page 16 Roles of nanotechnology in electrochemical sensors for medical diagnostic purposes: A review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What would likely happen if the bioreceptor layer is poorly immobilized on the sensor surface?
|
3. Target biomolecules may not bind effectively, leading to weak or inaccurate signals |
|
If the bioreceptor layer is not well attached (poorly immobilized), the sensor can’t catch the target molecules properly. This leads to weak or wrong signals because the molecules don’t bind as they should. |
5.1.1 page 9 Digital sensing technologies in cancer care: A new era in early detection and personalized diagnosis |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which modification would most directly enhance electron transfer in the sensor system?
|
2. Incorporating carbon nanotubes on the electrode surface |
|
Carbon nanotubes help improve electron transfer in electrochemical sensors. They increase the surface area and conductivity, making the sensors more sensitive and faster. |
5.1.1 page 9 Digital sensing technologies in cancer care: A new era in early detection and personalized diagnosis |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
How can digital sensing technologies best support personalized cancer care?
|
|
|
Digital sensing technologies help personalize cancer care by tracking each patient’s unique symptoms and responses in real time, allowing better and more tailored treatment. |
4.3 page 7 Digital sensing technologies in cancer care: A new era in early detection and personalized diagnosis |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
If a clinician needs to monitor fatigue and motion in cancer patients at home, which device should be prioritized?
|
1. Digital ELISA chips |
|
Digital ELISA can find very small amounts of disease signals. It works well with mobile and wearable devices. This helps doctors check patients in real-time without needing big machines. |
Page 14 Digital sensing technologies in cancer care: A new era in early detection and personalized diagnosis |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why is combining sensor data with patient-reported outcomes (PROs) important in digital cancer care?
|
3. It allows a holistic understanding of patient experience |
|
By combining sensor data with patient-reported outcomes (PROs), doctors can understand both what’s happening in the body and how the patient feels. This gives a full picture of their condition. |
“Integrating sensor-generated data with PROs offers a more comprehensive view of patient health, capturing both objective measurements and subjective experiences.” Page 16 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
A hospital invested in wearable digital monitoring but received low engagement from patients. Which of the following is most likely a contributing factor?
|
3. Low digital health literacy among patients |
|
If patients don’t understand how to use digital tools like wearable devices, they are less likely to use them even if the hospital invests in them. |
“Limited digital literacy among patients and providers remains a significant barrier to widespread adoption of digital health platforms.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which future trend is most aligned with the development of emerging digital cancer platforms?
|
2. Creation of pocket-sized biosensing tools integrated with smartphones |
|
Small and smart sensors that work with phones are part of the future of digital cancer care. They help doctors check patients easily, anywhere. |
5.3 page 12 Digital sensing technologies in cancer care: A new era in early detection and personalized diagnosis |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How can real-time symptom monitoring positively affect treatment decisions?
|
3. By enabling rapid intervention before major deterioration |
|
Real-time symptom monitoring helps doctors act quickly before the patient’s condition gets worse. |
“Continuous monitoring enables early intervention, potentially reducing hospitalizations and improving treatment outcomes.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which technology is best suited to detect rare cancer biomarkers with high precision?
|
1. Digital ELISA |
|
Digital ELISA is very good at finding tiny amounts of cancer biomarkers, which helps detect rare cancers early. |
“Digital ELISA offers ultra-sensitive protein detection, making it well-suited for identifying rare biomarkers with high precision.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
Why is collaboration between data scientists and clinicians essential in digital oncology platforms?
|
3. Data insights require clinical validation for real-world use |
|
Data scientists can find patterns, but doctors need to check if those patterns actually help real patients. Working together makes sure the results are useful in hospitals. |
“While AI and data analytics can uncover significant trends, their clinical relevance must be validated by healthcare professionals to ensure safe and effective implementation.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
Which outcome is most likely when cancer patients actively use digital health tools to track their condition?
|
2. They engage more actively in shared treatment decisions |
|
When cancer patients use digital health tools, they better understand their condition. This helps them work with doctors to make decisions together. |
“Digital health tools promote patient engagement by enabling individuals to track their own symptoms and health trends, leading to more informed and collaborative treatment planning.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
A research team is developing a highly selective electrochemical sensor for detecting cancer biomarkers in blood. Based on the diagram, which combination of nanoparticle properties would most likely enhance both specificity and signal sensitivity?
|
2. Small spherical particles with antibody-conjugated targeting ligands |
|
Small and round (spherical) particles have a bigger surface area to catch signals. When they are combined with antibodies that can find specific cancer markers, they help the sensor work better. This makes it easier to detect cancer signs early and accurately. |
“Functionalization of nanoparticles with specific ligands such as antibodies enables precise targeting and enhances sensitivity for cancer detection.” Table 3 page4 Roles of nanotechnology in electrochemical sensors for medical diagnostic purposes: A review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
A hospital is planning to adopt a single digital sensing platform to support a wide range of diagnostic applications. Based on the image, which of the following most justifies this decision?
|
2. One platform can be customized to detect toxins, cancer biomarkers, and heavy metals using interchangeable biorecognition elements |
|
Digital sensing platforms, especially those using lab-on-a-chip (LOC) or microfluidic systems, are flexible and adaptable. According to the document, they can detect many types of targets such as cancer biomarkers, toxins, and heavy metals by changing the recognition parts on the same chip. |
8.3.1 page 20 Roles of nanotechnology in electrochemical sensors for medical diagnostic purposes: A review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|